Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation.
Allogeneic hematopoietic cell transplantation (HCT) is the treatment of choice for a variety of hematologic malignancies and disorders. Unfortunately, acute graft-versus-host disease (GVHD) is a frequent complication of HCT. While substantial research has identified clinical, genetic and proteomic r...
Main Authors: | Catherine Lee, Sebastien Haneuse, Hai-Lin Wang, Sherri Rose, Stephen R Spellman, Michael Verneris, Katharine C Hsu, Katharina Fleischhauer, Stephanie J Lee, Reza Abdi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5773230?pdf=render |
Similar Items
-
Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01) -
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in children
by: Y. V. Skvortsova, et al.
Published: (2016-12-01) -
Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation
by: Vaneuza A. M. Funke, et al. -
Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant
by: Geary, Joshua J.
Published: (2016) -
Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
by: Natalia M. Tijaro-Ovalle, et al.
Published: (2019-03-01)